Clinical trial
Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With…
NCT00043303 · InterMune, Industry · Completed
Key facts
| NCT number | NCT00043303 |
|---|---|
| Title | Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis |
| Official title | A Multicenter Study of the Safety and Anti-Fibrotic Efficacy of Interferon-Gamma 1b (Actimmune) in Patients With Severe Lever Fibrosis or Compensated Cirrhosis Due to Hepatitis C. |
| Lead sponsor | InterMune, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Fibrosis, Cirrhosis |
| Intervention type | Drug |
| Interventions | interferon gamma-1b |
| Enrollment | 502 |
| Start date | Sep 1, 2001 |
| Completion | Nov 1, 2003 |
| First posted | Aug 9, 2002 |
| Last update posted | Nov 1, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: